Without a strong understanding of current market conditions and key value drivers, pharmaceutical companies struggle to set optimal launch prices. However, sales expectations are higher than ever for new drugs. Poor launch performance signals long-term challenges that can prove extremely difficult to overcome. So while in the process of preparing for the release of a new orphan drug in the US market, one pharmaceutical company appointed Pricing Solutions to help them execute a confident go -to-market strategy. The pharma company, among the world’s 50 largest, estimated sales for the drug would peak at approximately $500 million though it believed its orphan drug brought much more value to the market. The Challenge The company did not have a strong understanding of n

Join for free to read